Millioni Chhabra, a scientist working on finding cure for HIV in North Carolina USA

Investors Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

GSK investor event

Emma Walmsley CEO speaking at GSK Investor event
Emma Walmsley, CEO, speaking at the investor event

We announced our second quarter 2017 results and hosted an investor event on 26 July. At the investor event Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our key priorities and financial outlook.

Investor event
Watch the investor event videos
Emma Walmsley presentation: Key priorities
Simon Dingemans presentation: Q2 and financial outlook
Investor event full transcript

Our new business priorities
At the investor event we set out our new business priorities - centred around Innovation, Performance and Trust - which we will implement from 2018 onwards. 
See our new business priorities

Latest information

Annual Report and Responsible Business Supplement 2016

View our Annual Report 2016 summary and download the full Annual Report and Responsible Business Supplement.